AxialBridge (formerly Knowde Group) is dedicated to providing support services to organisations looking to bring novel, emerging therapies to market and increase access to patients. Our services are specifically targeted to help organisations meet the challenges of working with novel methods and approaches including emerging therapies, digital health and the use of Artificial Intelligence in drug discovery.